These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 10755531

  • 1. Postransplant lymphoproliferative disorder localized near the allograft in renal transplantation.
    Kew CE, Lopez-Ben R, Smith JK, Robbin ML, Cook WJ, Gaston RS, Deierhoi MH, Julian BA.
    Transplantation; 2000 Mar 15; 69(5):809-14. PubMed ID: 10755531
    [Abstract] [Full Text] [Related]

  • 2. Renal allograft involvement by Epstein-Barr virus associated post-transplant lymphoproliferative disease.
    Randhawa PS, Magnone M, Jordan M, Shapiro R, Demetris AJ, Nalesnik M.
    Am J Surg Pathol; 1996 May 15; 20(5):563-71. PubMed ID: 8619421
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
    Rouphael B, Lankireddy S, Lazaryan A, Kukla A, Ibrahim HN, Matas AJ, Issa N.
    Clin Transplant; 2016 Jan 15; 30(1):60-5. PubMed ID: 26497471
    [Abstract] [Full Text] [Related]

  • 4. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
    Purighalla R, Shapiro R, Jordan ML, Scantlebury VP, Gritsch HA, Vivas C, Randhawa PS.
    Clin Transplant; 1997 Dec 15; 11(6):574-6. PubMed ID: 9408687
    [Abstract] [Full Text] [Related]

  • 5. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 15; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 6. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM, Alhomayeed B, Soliman N, Weir MA, House AA.
    Transpl Infect Dis; 2016 Jun 15; 18(3):423-30. PubMed ID: 27016725
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression.
    Ellis D, Jaffe R, Green M, Janosky JJ, Lombardozzi-Lane S, Shapiro R, Scantlebury V, Vivas C, Jordan ML.
    Transplantation; 1999 Oct 15; 68(7):997-1003. PubMed ID: 10532541
    [Abstract] [Full Text] [Related]

  • 8. Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. PTLD French Working Group.
    Caillard S, Lachat V, Moulin B.
    Transpl Int; 2000 Oct 15; 13 Suppl 1():S388-93. PubMed ID: 11112039
    [Abstract] [Full Text] [Related]

  • 9. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M, Badwal S, Pandey R, Srivastava A, Sharma RK, Gupta RK.
    Clin Transplant; 2005 Oct 15; 19(5):668-73. PubMed ID: 16146560
    [Abstract] [Full Text] [Related]

  • 10. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M, Thakral B, Yohe S, Balfour HH, Singh C, Spears M, McKenna RW.
    Am J Surg Pathol; 2014 Nov 15; 38(11):1522-9. PubMed ID: 25007145
    [Abstract] [Full Text] [Related]

  • 11. Discrimination of Epstein-Barr virus-related posttransplant lymphoproliferations from acute rejection in lung allograft recipients.
    Rosendale B, Yousem SA.
    Arch Pathol Lab Med; 1995 May 15; 119(5):418-23. PubMed ID: 7748068
    [Abstract] [Full Text] [Related]

  • 12. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
    Shapiro R, Nalesnik M, McCauley J, Fedorek S, Jordan ML, Scantlebury VP, Jain A, Vivas C, Ellis D, Lombardozzi-Lane S, Randhawa P, Johnston J, Hakala TR, Simmons RL, Fung JJ, Starzl TE.
    Transplantation; 1999 Dec 27; 68(12):1851-4. PubMed ID: 10628763
    [Abstract] [Full Text] [Related]

  • 13. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
    Chen DB, Wang Y, Song QJ, Shen DH.
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep 27; 41(9):607-12. PubMed ID: 23157829
    [Abstract] [Full Text] [Related]

  • 14. Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature.
    Ferguson NN, Thomas CP, Hohl RJ, Syrbu SI, Stone MS, Wanat KA.
    Am J Dermatopathol; 2015 Oct 27; 37(10):790-4. PubMed ID: 25747810
    [Abstract] [Full Text] [Related]

  • 15. Thoracic presentations of posttransplant lymphoproliferative disorders.
    Halkos ME, Miller JI, Mann KP, Miller DL, Gal AA.
    Chest; 2004 Dec 27; 126(6):2013-20. PubMed ID: 15596707
    [Abstract] [Full Text] [Related]

  • 16. An approach to finding indications and contraindications for nephrectomy in post-transplant renal graft lymphomas: PTLD.Int survey.
    Gholipour-Shoiili A, Gholipour-Shoiili H, Taheri S.
    Hematol Oncol Stem Cell Ther; 2011 Dec 27; 4(4):167-72. PubMed ID: 22198192
    [Abstract] [Full Text] [Related]

  • 17. Effective treatment of high-grade lymphoproliferative disorder after renal transplantation using autologous lymphocyte activated killer cell therapy.
    Li PK, Tsang K, Szeto CC, Wong TY, To KF, Leung CB, Lui SF, Yu S, Lai FM.
    Am J Kidney Dis; 1998 Nov 27; 32(5):813-9. PubMed ID: 9820452
    [Abstract] [Full Text] [Related]

  • 18. Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature.
    Banks CA, Meier JD, Stallworth CR, White DR.
    Ann Otol Rhinol Laryngol; 2012 May 27; 121(5):291-5. PubMed ID: 22724273
    [Abstract] [Full Text] [Related]

  • 19. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
    Srivastava T, Zwick DL, Rothberg PG, Warady BA.
    Pediatr Nephrol; 1999 Nov 27; 13(9):748-54. PubMed ID: 10603113
    [Abstract] [Full Text] [Related]

  • 20. Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center.
    Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA.
    Transplantation; 1993 Jul 27; 56(1):88-96. PubMed ID: 8333073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.